caribou biosciences stock forecast

Caribou Biosciences is a leading clinical-stage CRISPR genome editing biotechnology company developing an internal pipeline of off-the-shelf genome-edited CAR-T and natural killer NK cell therapies. Modernas stock rose 28X in the past 2 years are these biotech picks next.

Caribou Biosciences Stock Selling Close To Cash Balance Nasdaq Crbu Seeking Alpha

Caribou Biosciences Double Exponential Smoothing.

. Based on 6 Wall Street analysts offering 12 month price targets for Caribou Biosciences in the last 3 months. CRBU stock price quote with breaking news financials statistics charts and more. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

The company is making clinical progress. Caribou Biosciences Forecast Revenue Growth Data Unavailable Analysts estimate an earnings increase this quarter of 008 per share a decrease next quarter of 000 per share an increase this year of 051 per share and a decrease next year of 000 per share. InvestorsObserver gives Caribou Biosciences Inc CRBU an overall rank of 42 which is below average.

During the day the. Caribou Biosciences Inc. It edits a type.

3002 45285 upside. The average price target represents a 30943 change from the last price of 679. Skip to main content.

Past 12 Months 12 Months Forecast 5 13 21 29 37 Oct 2021 Jan 2022 Apr 2022. CRBU is penciling in a 100 million initial public offering. Wainwright Thinks Caribou Biosciences Stock is Going to Recover June 13 2022 TipRanks Brookline Capital Markets Keeps Their Buy Rating on Caribou Biosciences CRBU June 10.

Caribou Biosciences Stock Forecast down to 0 - CRBU Price Prediction. Now is the time to move. Ad Build Your Portfolio Your Way.

A rank of 42 means that 58 of stocks appear more favorable to our system. What is the 52 week high and low for Caribou Biosciences NASDAQ. Find the latest Caribou Biosciences Inc.

Ad These 5 companies are set for historic price action. It will be exciting to see whether it manages to continue. Rooms Shows Rankings Earnings Newsletters Shop.

Get a real-time Caribou Biosciences Inc. Our Financial Advisors Offer a Wealth of Knowledge. Based on 6 Wall Street analysts offering 12 month price targets for Caribou Biosciences in the last 3 months.

2011 Funding to Date. Buy or sell Caribou Biosciences stock Learn more. The average CARIBOU BIOSCIENCES stock price prediction forecasts a potential upside of 47297 from the current CRBU share price of 555.

The Caribou Biosciences Inc. Ad Biotech is becoming one of the best new sectors for investing if you know where to look. Find the latest Caribou Biosciences Inc.

What analysts cover Caribou Biosciences. Caribou Biosciences Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stocks chart. A high-level overview of Caribou Biosciences Inc.

Caribous lead candidate is a therapy to fight B-cell non-Hodgkins Lymphoma. The 10 analysts offering price forecasts for Caribou Biosciences have a median target of 3000 with a high estimate of 3900 and a low estimate of. The average price target is 2780 with a high forecast of 3600 and a low forecast of 1900.

Stock Price Forecast The 7 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 2800 with a high estimate of 3900 and a low estimate of 1900. Summary of all time highs changes and price drops for Caribou Biosciences. Analysis of Caribou Biosciences Double Exponential Smoothing Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponentia.

The price has fallen in 6 of the last 10 days and is down by. Real-time trade and investing ideas on Caribou Biosciences Inc CRBU from the largest community of traders and investors. Caribou Biosciences stock quotes can also be displayed as NASDAQ.

Caribou Biosciences has been rated by Citigroup and SVB Leerink in the past 90 days. And has now gained 3 days in a row. CRBU CARIBOU BIOSCIENCES stock price per share is 794 today as of Apr 11 2022.

It is currently -792 from its 52-week high and 3885 from its 52-week low. Caribou Biosciences Stock Forecast. The average rating for CRBU stock is Buy The 12-month stock price forecast is 3002 which is an increase of 45285 from the latest price.

A rare market phenomena could change everything and theres no telling when it will occur. Analyst estimates including CRBU earnings per share estimates and analyst recommendations. Log In Free.

CRBU stock quote history news and other vital information to help you with your stock trading and investing. Stock Price Forecast According to 13 stock analysts the average 12-month stock price forecast for CRBU stock is 3002 which predicts an increase of 4409. Caribou Biosciences Inc 534 009 166 Watch.

On average analysts rate CRBU stock as a buy. Stock price gained 247 on the last trading day Wednesday 6th Jul 2022 rising from 566 to 580. CRBU Caribou Biosciencess 52-week high was 3265 and its 52-week low was 489.

The average CARIBOU BIOSCIENCES stock price prediction forecasts a potential upside of 28378 from the current CRBU share price of 740. The lowest target is 1919 and the highest is 4095. Green day on Wednesday for Caribou Biosciences IncUpdated on Jul 06 2022 Sell candidate since 2022-06-10 Loss -1643 PDF.

According to analysts Caribou Biosciencess stock has a predicted upside of 9484 based on their 12-month price targets. CRBU analyst stock forecast price target and recommendation trends with in-depth analysis from research. On average Wall Street analysts predict that CARIBOU BIOSCIENCES s share price could reach 3180 by May 13 2023.

Global Crispr Market Competition Landscape 2021 2028 Featuring Profiles Of Integrated Dna Technologies Intellia Therapeutics Horizon Discovery Group And Precision Biosciences Among Others